TNON Stock Price, Tenon Medical, Inc. Quote, Chart

Market Summary

USD0.75+0.02

Market Closed

2.74%

TNON Stock Price

View Fullscreen

TNON RSI Chart

TNON Valuation

Market Cap

2.8M

Price/Earnings (Trailing)

-0.18

Price/Sales (Trailing)

0.95

Price/Free Cashflow

-0.23

TNON Price/Sales (Trailing)

TNON Profitability

Operating Margin

42.38%

Return on Equity

-2.0K%

Return on Assets

-245.56%

Free Cashflow Yield

-435.85%

TNON Fundamentals

TNON Revenue

Revenue (TTM)

2.9M

Rev. Growth (Yr)

191.7%

Rev. Growth (Qtr)

-14.41%

TNON Earnings

Earnings (TTM)

-15.6M

Earnings Growth (Yr)

60.35%

Earnings Growth (Qtr)

5.94%

Breaking Down TNON Revenue

Last 7 days

2.7%

Last 30 days

-16.7%

Last 90 days

-40.9%

Trailing 12 Months

-58.8%

How does TNON drawdown profile look like?

TNON Financial Health

Current Ratio

1.24

TNON Investor Care

Shares Dilution (1Y)

231.25%

Diluted EPS (TTM)

-9.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.1M	1.7M	2.4M	2.9M
2022	216.0K	329.0K	467.0K	691.0K
2021	0	0	0	160.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Tenon Medical, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 27, 2023	ginn richard	sold (taxes)	-4,604	2.0001	-2,302	chief technology officer
Nov 27, 2023	foster steven m	sold (taxes)	-1,802	2.0001	-901	ceo and president
Nov 22, 2023	van dick steven m	acquired	3,074	2.02	1,522	chief financial officer
Nov 22, 2023	ginn richard	acquired	15,182	2.02	7,516	chief technology officer
Nov 22, 2023	foster steven m	acquired	7,320	2.02	3,624	ceo and president
Jun 14, 2023	van dick steven m	bought	13,650	0.273	50,000	chief financial officer
May 23, 2023	ginn richard	sold	-81,887	1.26	-64,990	chief technology officer
May 23, 2023	foster steven m	sold	-35,016	1.26	-27,791	ceo and president
May 22, 2023	ferrari richard	acquired	147,906	1.62	91,300	-
May 22, 2023	fischer frank m	acquired	10,055	1.62	6,207	-

Which funds bought or sold TNON recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Spectrum Asset Management, Inc. (NB/CA)	unchanged	-	45,689	62,916	0.03%
Apr 23, 2024	Spectrum Asset Management, Inc. (NB/CA)	unchanged	-	-52,455	79,098	0.03%
Mar 11, 2024	VANGUARD GROUP INC	new	-	37,689	37,689	-%
Feb 20, 2024	Cable Car Capital LLC	new	-	40,656	40,656	0.04%
Feb 14, 2024	TWO SIGMA SECURITIES, LLC	sold off	-100	-3,065	-	-%
Feb 14, 2024	CITADEL ADVISORS LLC	added	288	2,729	3,142	-%
Feb 14, 2024	Royal Bank of Canada	new	-	-	-	-%
Feb 14, 2024	Royal Bank of Canada	sold off	-100	-	-	-%
Feb 14, 2024	MILLENNIUM MANAGEMENT LLC	sold off	-100	-7,087	-	-%
Feb 14, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	sold off	-100	-6,233	-	-%

Are Funds Buying or Selling TNON?

Are funds buying TNON calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TNON

No. of Funds

Unveiling Tenon Medical, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 16, 2024	tmd wealth management, llc	25.40%	941,888	SC 13G
Feb 14, 2024	tmd wealth management, llc	31.56%	2,984,262	SC 13G/A
Sep 13, 2023	tmd wealth management, llc	32.58%	8,712,362	SC 13G/A

Recent SEC filings of Tenon Medical, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 16, 2024	SC 13G	Major Ownership Report
Apr 08, 2024	SC TO-I	SC TO-I
Apr 01, 2024	8-K	Current Report
Mar 29, 2024	3	Insider Trading
Mar 29, 2024	10-K	Annual Report
Mar 14, 2024	8-K	Current Report
Feb 28, 2024	D	D
Feb 22, 2024	8-K	Current Report
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	5	Insider Trading

Tenon Medical, Inc. News

Latest updates

Tenon Medical, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)												(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1
Revenue	-14.4%	808	944	743	433	277	208	135	71.00	53.00	70.00	22.00	15.00
Cost Of Revenue	-39.1%	249	409	549	480	484	302	271	275	17.00	18.00	9.00	11.00
Gross Profit	4.5%	559	535	194	-47.00	-207	-94.00	-136	-204	36.00	52.00	13.00	4.00
Operating Expenses	-5.4%	3,700	3,913	4,516	4,839	7,721	3,168	5,320	1,875	2,598	2,149	1,626	193
S&GA Expenses	-12.1%	1,342	1,527	1,883	2,026	4,969	645	1,943	276	668	556	913	4.00
R&D Expenses	-6.2%	691	737	901	834	812	797	657	562	793	601	237	87.00
Interest Expenses	325.0%	17.00	4.00	-	-	-8.00	-	88.00	274	281	267	62.00	11.00
Income Taxes	-	-	-	-	-	-	-	-	-	-	-	1.00	-
Net Income	5.9%	-3,134	-3,332	-4,285	-4,830	-7,905	-3,171	-5,488	-2,353	-2,842	-2,341	-1,665	-200
Net Income Margin	37.3%	-5.32*	-8.49*	-12.16*	-20.32*	-27.38*	-29.67*	-39.59*	-42.60*	-44.05*	-	-	-
Free Cashflow	29.0%	-2,278	-3,210	-3,304	-3,660	-3,986	-3,490	-2,804	-2,592	-1,774	-1,429	-1,029	-162

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet									(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Assets	-13.3%	6,345	7,318	9,855	7,629	11,089	14,937	18,131	7,145	9,272
Current Assets	-21.6%	3,889	4,963	7,929	5,841	9,347	13,665	16,858	5,425	7,672
Cash Equivalents	-28.0%	2,428	3,371	5,852	3,179	2,129	3,153	7,875	4,677	2,917
Inventory	16.9%	554	474	570	416	415	810	628	602	188
Net PPE	0.5%	961	956	945	852	793	294	241	219	101
Liabilities	16.0%	5,567	4,801	8,952	5,155	4,837	1,990	3,018	16,241	16,185
Current Liabilities	1.8%	3,140	3,085	6,866	2,752	2,530	1,266	2,236	15,402	15,274
Shareholder's Equity	-69.1%	778	2,517	903	2,474	6,252	12,947	15,113	-	-20,552
Retained Earnings	-6.0%	-55,073	-51,939	-48,607	-44,322	-39,492	-31,587	-28,416	-22,928	-20,575
Additional Paid-In Capital	2.5%	55,894	54,556	49,560	46,873	45,843	44,691	43,657	282	113
Shares Outstanding	5.2%	2,600	2,471	2,162	1,125	1,124	1,124	1,124	99.00	99.00
Float	-	-	-	4,892	-	-	-	17,509	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)												(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1
Cashflow From Operations	27.8%	-2,278	-3,153	-3,176	-3,576	-3,385	-3,413	-2,763	-2,464	-1,690	-1,411	-1,029	-162
Share Based Compensation	-8.3%	981	1,070	1,054	1,040	1,142	1,034	552	169	169	143	61.00	4.00
Cashflow From Investing	-121.1%	-92.00	436	1,129	4,669	2,339	-1,317	-8,182	4,276	3,375	-7,879	-	-
Cashflow From Financing	415.4%	1,371	266	4,707	-42.00	-25.00	-	14,193	-54.00	-179	3,786	7,892	-30.00

TNON Income Statement

2023-12-31

Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue	$ 2,928	$ 691
Cost of sales	1,687	1,332
Gross Profit (Loss)	1,241	(641)
Operating Expenses
Research and development	3,163	2,828
Sales and marketing	6,778	7,833
General and administrative	7,027	7,423
Total Operating Expenses	16,968	18,084
Loss from Operations	(15,727)	(18,725)
Other Income (Expense)
Gain on investments	167	180
Interest expense	(21)	(354)
Other expense, net		(18)
Total Other Income (Expense), net	146	(192)
Net Loss	$ (15,581)	$ (18,917)
Net Loss Per Share of Common Stock
Basic (in Dollars per share)	$ (8.59)	$ (23.62)
Weighted-Average Shares of Common Stock Outstanding
Basic (in Shares)	1,814	801
Consolidated Statements of Comprehensive Loss:
Net loss	$ (15,581)	$ (18,917)
Unrealized loss on investments	16	(16)
Foreign currency translation adjustment	38	7
Total Comprehensive Loss	$ (15,527)	$ (18,926)

TNON Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 2,428	$ 2,129
Short-term investments		6,441
Accounts receivable	518	228
Inventory, net	554	415
Prepaid expenses	389	134
Total current assets	3,889	9,347
Fixed assets, net	961	793
Deposits	51	51
Operating lease right-of-use asset	646	873
Deferred offering costs	798	25
TOTAL ASSETS	6,345	11,089
Current liabilities:
Accounts payable	433	550
Accrued expenses	808	717
Current portion of accrued commissions	470	1,035
Current portion of operating lease liability	256	228
Convertible notes payable and accrued interest, net of debt discount of $77 and $0 at December 31, 2023 and 2022, respectively	1,173
Total current liabilities	3,140	2,530
Accrued commissions, net of current portion	1,999	1,624
Operating lease liability, net of current portion	428	683
Total liabilities	5,567	4,837
Commitments and contingencies (Notes 6 and 10)
Stockholders’ equity:
Common stock, $0.001 par value; 130,000,000 shares authorized at December 31, 2023 and 2022; 2,600,311 and 1,123,680 shares issued and outstanding at December 31, 2023 and 2022, respectively	3	1
Additional paid-in capital	55,894	45,843
Accumulated deficit	(55,073)	(39,492)
Accumulated other comprehensive loss	(46)	(100)
Total stockholders’ equity	778	6,252
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 6,345	$ 11,089

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

CEO	Mr. Steven M. Foster
WEBSITE	tenonmed.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	22

Tenon Medical, Inc. Frequently Asked Questions

What is the ticker symbol for Tenon Medical, Inc.? What does TNON stand for in stocks?

TNON is the stock ticker symbol of Tenon Medical, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tenon Medical, Inc. (TNON)?

As of Fri Apr 26 2024, market cap of Tenon Medical, Inc. is 2.8 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TNON stock?

You can check TNON's fair value in chart for subscribers.

What is the fair value of TNON stock?

You can check TNON's fair value in chart for subscribers. The fair value of Tenon Medical, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Tenon Medical, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TNON so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Tenon Medical, Inc. a good stock to buy?

The fair value guage provides a quick view whether TNON is over valued or under valued. Whether Tenon Medical, Inc. is cheap or expensive depends on the assumptions which impact Tenon Medical, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TNON.

What is Tenon Medical, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, TNON's PE ratio (Price to Earnings) is -0.18 and Price to Sales (PS) ratio is 0.95. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TNON PE ratio will change depending on the future growth rate expectations of investors.